Corridor Business Journal: University of Iowa Hospitals & Clinics, the site of one of Pfizer’s coronavirus vaccine trials, says it could begin distributing the vaccine as soon as late November. The UI’s lead COVID-19 vaccine responder Dr. Brooks Jackson tells the Daily Iowan that despite widespread worries about political meddling, the vaccine could be ready within weeks, although it will be months before everyone has access. Dr. Jackson, who also serves as dean of the UI College of Medicine and the UI’s vice president for medical affairs, said the Pfizer vaccine trial has moved faster than any previous trials for vaccines, showing success in its first two trial phases and positioning it for emergency approval from the FDA next month. Researchers are testing 48 vaccines in clinical trials on humans in a race to be first with a safe and effective vaccine, according to the New York Times. The paper notes that President Donald Trump has frequently touted Pfizer’s progress, hinting that a vaccine would be available before the election – a notion Pfizer’s CEO has thrown cold water on.